Anticholinergics

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• Muscarinic Receptor Blockade: Anticholinergic (more accurately termed antimuscarinic) toxicity results from the competitive blockade of muscarinic acetylcholine receptors.
• Relative Sympathomimesis: Blocking normal cholinergic tone disrupts the homeostatic balance between the sympathetic and parasympathetic nervous systems, allowing the sympathetic arm to function unopposed.
• Secretory Failure and Hyperthermia: Because the secretory glands of the skin and mucous membranes rely on muscarinic receptors, their blockade leads to a profound cessation of sweating (anhidrosis) and mucous production. The inability to sweat severely impairs the body's primary mechanism for heat dissipation, leading to potentially life-threatening hyperthermia.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Immediate Stabilization: Secure the airway if the patient is severely delirious or seizing, and initiate continuous cardiac monitoring.
• Temperature Control: Initiate immediate active cooling (e.g., ice baths, evaporative cooling) for hyperthermia.
• Agitation and Seizure Control: Administer intravenous benzodiazepines to control agitation and prevent rhabdomyolysis from excessive muscle breakdown.
• Dosage: Lorazepam 1 to 2 mg IV or Diazepam 5 to 10 mg IV. Additional doses can be administered every 10 minutes until the patient is calm and able to cooperate with care.
• The Antidote (Physostigmine): For severe anticholinergic toxicity featuring refractory severe agitation and delirium, administer a cholinesterase inhibitor to temporarily overcome the muscarinic blockade.
• Dosage: Physostigmine 0.5 to 2 mg IV for adults (or 0.02 mg/kg in children).

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

• The "Can't-Miss" Mimics:
• Sympathomimetic Toxicity (e.g., Cocaine, Amphetamines, Pseudoephedrine): Presents nearly identically with tachycardia, hyperthermia, and delirium, but these patients will be profoundly diaphoretic (sweaty), unlike the bone-dry anticholinergic patient.
• Sepsis / Meningitis: Must be considered in any hyperthermic, tachycardic, and delirious patient.
• Prioritized Diagnostic Workup:
• Co-Ingestion Panel (Mandatory): Obtain a serum acetaminophen level and salicylate level. Over-the-counter sleep aids commonly contain anticholinergics (diphenhydramine or doxylamine) co-formulated with acetaminophen, making occult hepatic toxicity a massive risk.
• Basic Labs & CPK: In patients with moderate to severe toxicity, check serum glucose, electrolytes, renal function, and creatine kinase (to evaluate for rhabdomyolysis due to extreme agitation/myoclonus).
• Do NOT Order: A urine drug screen. It is almost never helpful in determining treatment and will fail to detect most medications responsible for this syndrome.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• The "Toxidrome" Physical Exam: Actively assess for the classic toxidrome checklist:
• Mad as a hatter: Delirium, hallucinations, picking at the air/clothing, choreoathetoid movements.
• Hot as a hare: Severe hyperthermia.
• Blind as a bat: Mydriasis (dilated pupils).
• Red as a beet: Flushed skin.
• Dry as a bone: Bone-dry skin and mucous membranes, urinary retention (palpate for a distended bladder), and absent bowel sounds.
• The 12-Lead ECG (Critical): You must actively look for a widened QRS complex, prolonged QTc interval, and a dominant terminal R wave in lead aVR. Tricyclic antidepressants (TCAs) possess potent anticholinergic properties; missing a TCA overdose will lead to fatal cardiac dysrhythmias.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

While no specific named scoring tool dictates disposition for anticholinergic toxicity, disposition is strictly stratified by symptom severity and clinical progression:

• Mild Toxicity: Patients with a clear history of exposure and mild symptoms (e.g., dry mouth, mild tachycardia) require only supportive care, observation, and can be discharged once symptoms resolve.
• Moderate/Severe Toxicity: Patients presenting with an unclear history, hyperthermia, profound delirium, or those requiring physostigmine or large doses of benzodiazepines require an extensive laboratory workup (to rule out end-organ toxicity like rhabdomyolysis) and mandate hospital admission.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• The Sympathomimetic Diagnostic Trap: Pitfall: Confusing anticholinergic toxicity with sympathomimetic overdose. Critical Action: Touch the patient's skin, specifically the axillae. If the patient is diaphoretic (sweaty), it is sympathomimetic toxicity (e.g., cocaine, pseudoephedrine). If the patient is bone-dry, it is anticholinergic.
• The Occult Acetaminophen Trap: Pitfall: Treating the acute diphenhydramine overdose but missing the lethal acetaminophen co-ingestion. Critical Action: Routinely draw an acetaminophen level on all patients presenting with sleep-aid overdoses.
• The UDS Trap: Pitfall: Delaying treatment or relying on a urine drug screen to confirm the diagnosis. Critical Action: UDS is useless for this toxidrome; diagnose and treat clinically based on the physical exam.

7. MCQ MASTERCLASS (Written Exam Tips)

• Classic Scenario / Buzzwords: A patient presents after drinking an "herbal tea" or "Jimson weed." They are agitated, have a resting tachycardia, and exhibit "picking movements" of the fingers. -> Exam Answer: Anticholinergic toxicity (treat with Lorazepam or Physostigmine).
• The "Sweat" Distractor: A question describes an agitated, tachycardic patient who is diaphoretic. An option will suggest Diphenhydramine or Jimson weed. -> Correction: Diaphoresis points to pseudoephedrine, cocaine, or amphetamines, not anticholinergics.
• TCA Distractor: A patient presents with classic anticholinergic signs. The next best step is asked. -> Exam Answer: Obtain an ECG. TCAs cause antimuscarinic symptoms but kill via sodium channel blockade leading to cardiac dysrhythmias.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• The Initial Declaration: "The patient is presenting with tachycardia, profound delirium, flushed dry skin, and mydriasis. This is the classic anticholinergic toxidrome. I am placing the patient on continuous cardiac monitoring, establishing IV access, and initiating active cooling for their hyperthermia."
• The Medication Strategy: "The patient is severely agitated. I will administer 2 mg of IV Lorazepam to control the agitation and prevent rhabdomyolysis. If the delirium is severe and refractory to benzodiazepines, I will prepare to administer 0.5 to 2 mg of IV Physostigmine."
• The Diagnostic Safety Net: "I am ordering a STAT 12-lead ECG to evaluate the QRS and QTc intervals to rule out a fatal tricyclic antidepressant overdose. Because many over-the-counter anticholinergic sleep aids contain acetaminophen, I am also drawing a serum acetaminophen level to rule out a lethal co-ingestion."